Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medicaid drugs.

John A Poisal1

  • 1Centers for Medicare & Medicaid Services, 7500 Security Boulevard, C3-16-27, Baltimore, MD 21244-1850, USA. jpoisal@cms.hhs.gov

Health Care Financing Review
|July 3, 2004
PubMed
Summary

This commentary reviews prescription drug issues in Medicaid, including drug spending trends, access challenges, and generic drug cost-containment strategies. It also examines Australia's pharmaceutical delivery system.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National Health Expenditure Projections, 2025-34: Strong Utilization Growth Initially, Legislative Impacts Later.

Health affairs (Project Hope)·2026
Same author

National Health Expenditure Projections, 2024-33: Despite Insurance Coverage Declines, Health To Grow As Share Of GDP.

Health affairs (Project Hope)·2025
Same author

National Health Expenditure Projections, 2023-32: Payer Trends Diverge As Pandemic-Related Policies Fade.

Health affairs (Project Hope)·2024
Same author

National Health Expenditure Projections, 2022-31: Growth To Stabilize Once The COVID-19 Public Health Emergency Ends.

Health affairs (Project Hope)·2023
Same author

National Health Expenditure Projections, 2021-30: Growth To Moderate As COVID-19 Impacts Wane.

Health affairs (Project Hope)·2022
Same author

National Health Expenditure Projections, 2019-28: Expected Rebound In Prices Drives Rising Spending Growth.

Health affairs (Project Hope)·2020

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Public Health

Background:

  • Medicaid prescription drug programs face complex challenges.
  • Understanding pharmaceutical delivery systems is crucial for policy development.

Purpose of the Study:

  • To analyze prescription drug expenditure trends within Medicaid.
  • To evaluate access to pharmaceuticals for Medicaid beneficiaries.
  • To assess the effectiveness of generic drug cost-containment initiatives.

Main Methods:

  • Review of multiple articles and commentaries.
  • Analysis of drug expenditure data.
  • Evaluation of policy interventions.

Main Results:

  • Identified key trends in Medicaid drug spending.
  • Highlighted significant barriers to pharmaceutical access.
  • Provided insights into generic drug cost-containment program outcomes.

Conclusions:

  • Comprehensive analysis of Medicaid drug policy is needed.
  • Policy interventions must address both cost and access.
  • International comparisons offer valuable perspectives on pharmaceutical systems.

Related Experiment Videos